Claudio Laudani: We Summarize Current Knowledge and Future Perspectives On The Role of Inflammation in Patients with MI
Claudio Laudani, Cardiovascular Disease Fellow UNICT, Post-Doc Research Scholar UFHealth JAX, shared on LinkedIn:
”Inflammation is a key driver of ischemic heart disease and myocardial infarction, having a central role in both the arterial wall and myocardial tissue.
Recently, novel approaches have reignited the interest in anti-inflammatory strategies after acute myocardial infarction.
However, key knowledge gaps remain regarding potential class effects, drug choice, patient selection, and the optimal administration timing.
In this state of the art review, we summarize current knowledge and future perspectives on the role of inflammation in patients with myocardial infarction, as well as potential targets and pharmacological treatments being currently under development.”
Read the full article in JACC.
Article: Targeting Inflammation After Acute Myocardial Infarction
Authors: Antonino Imbesi, Antonio Greco, Marco Spagnolo, Claudio Laudani, Carmelo Raffo, Simone Finocchiaro, Placido Maria Mazzone, Davide Landolina, Maria Sara Mauro, Luigi Cutore, Giacinto Di Leo, Denise Cristiana Faro, Nicola Ammirabile, Daniele Giacoppo, Davide Capodanno

Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia
